Scholarlink

<p><i>Staphylococcus aureus</i> can form aggregates within human synovial fluid, contributing to joint infections that are resistant to conventional therapies. However, the regulatory pathways underlying this process remain unclear. Here, we reveal that the <i>S. aureus</i> two-component system <i>saeRS</i> contributes to synovial aggregation by controlling the expression of fibrinectin-binding proteins A and B (FnbA/B), which bind to human fibrinogen and cause aggregation. We further demonstrate that the fatty acid kinase (<i>fak</i>) system is the primary regulator for SaeS activity under host conditions. Mechanistically, <i>fak</i> is epistatic to <i>saeRS</i> by scavenging exogenous fatty acids and altering the localization of SaeS into functional membrane microdomains (FMMs), which are essential for SaeS function. We also identify that undecanoic acid (UDA) is capable of inhibiting the <i>fak</i> pathway, demonstrating its efficacy and potential applicability in treating joint infections. Altogether, these findings highlight the <i>fak-saeRS</i> axis as a potential therapeutic target for joint infections and underscore UDA as a promising treatment for these infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Staphylococcus aureus fatty acid metabolism governs saeRS-mediated aggregation in joint infections

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月21日

查看全文
  • Jinlong Yu,
  • Mingzhang Li,
  • Changming Wang,
  • Musha Hamushan,
  • Yujie Hu,
  • Yi Yang,
  • Feng Jiang,
  • Jireng Yan,
  • Boyong Wang,
  • Xiaohua Chen,
  • Jin Tang,
  • Geyong Guo,
  • Pei Han,
  • Hao Shen

摘要

Staphylococcus aureus can form aggregates within human synovial fluid, contributing to joint infections that are resistant to conventional therapies. However, the regulatory pathways underlying this process remain unclear. Here, we reveal that the S. aureus two-component system saeRS contributes to synovial aggregation by controlling the expression of fibrinectin-binding proteins A and B (FnbA/B), which bind to human fibrinogen and cause aggregation. We further demonstrate that the fatty acid kinase (fak) system is the primary regulator for SaeS activity under host conditions. Mechanistically, fak is epistatic to saeRS by scavenging exogenous fatty acids and altering the localization of SaeS into functional membrane microdomains (FMMs), which are essential for SaeS function. We also identify that undecanoic acid (UDA) is capable of inhibiting the fak pathway, demonstrating its efficacy and potential applicability in treating joint infections. Altogether, these findings highlight the fak-saeRS axis as a potential therapeutic target for joint infections and underscore UDA as a promising treatment for these infections.